C07K 2319/05
Containing a golgi retention signal
Official title: containing a GOLGI retention signal
C07K2319/05 (Containing a golgi retention signal) appears on 40 US grants and 65 published applications in this corpus.
Search patents in C07K- Granted patents
- 40
- Published applications
- 65
- Assignees
- 38
- Inventors
- 94
- Latest grant
- 6 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 2 |
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 2 |
| 2006 | 2 | 5 |
| 2007 | 0 | 2 |
| 2008 | 1 | 2 |
| 2009 | 2 | 0 |
| 2010 | 1 | 6 |
| 2011 | 3 | 2 |
| 2012 | 2 | 1 |
| 2013 | 2 | 3 |
| 2014 | 1 | 3 |
| 2015 | 4 | 3 |
| 2016 | 1 | 1 |
| 2017 | 1 | 1 |
| 2018 | 0 | 6 |
| 2019 | 1 | 1 |
| 2020 | 3 | 3 |
| 2021 | 0 | 2 |
| 2022 | 3 | 3 |
| 2023 | 1 | 2 |
| 2024 | 4 | 6 |
| 2025 | 3 | 4 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Genetically engineered eukaryotic cells producing sialylated glycoproteins6 Jan 2026US 12,516,361 B2Universiteit Gent
- Molecular guide system peptides and uses thereof14 Oct 2025US 12,441,774 B2SRI International
- Immunomodulatory fusion protein-metal hydroxide complexes and methods thereof7 Oct 2025US 12,433,946 B2Massachusetts Institute of Technology
- Protein-based T-cell receptor knockdown11 Feb 2025US 12,221,482 B2UCL Business PLC
- Molecular guide system peptides and uses thereof23 Apr 2024US 11,965,004 B2SRI International
- Proteins, methods, and systems for subcellular localization of proteins for post-translation modification25 Jun 2026US 2026/0176314 A1Better Dairy Limited
- Immunomodulatory fusion protein-metal hydroxide complexes and methods thereof22 Jan 2026US 2026/0021177 A1Massachusetts Institute of Technology
- Molecular guide system peptides and uses thereof15 Jan 2026US 2026/0015395 A1SRI International
- Blockade of cd3 expression and chimeric antigen receptors for immunotherapy23 Oct 2025US 2025/0325587 A1MediSix Therapeutics, Inc.
- Fusion protein for inducing immune response and treating cancer24 Jul 2025US 2025/0235523 A1Taivital Biopharmaceutical Co. Ltd
Most cited
By later US patents
- Methods for producing modified glycoproteins158US 7,029,872 B2GlycoFi, Inc. · 2006
- Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures108US 5,324,663 AThe Regents of the University of Michigan · 1994
- Methods for producing modified glycoproteins84US 7,326,681 B2GlycoFi, Inc. · 2008
- Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures69US 5,955,347 AThe Regents of the University of Michigan · 1999
- Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures54US 5,595,900 AThe Regents of the University of Michigan · 1997